Clinical Trials
20 trialsNCT05108298 2026-05-07
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT06466382 2026-05-05
OVPrecision
Swiss GO Trial Group
Phase NA Recruiting
NCT07530679 2026-04-15
Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination
Jiangsu Province Centers for Disease Control and Prevention
Phase NA Not yet recruiting
NCT04831580 2024-12-19
ROCC
GOG Foundation
Phase NA Recruiting
NCT01658930 2024-12-17
SHAPE
Canadian Cancer Trials Group
Phase NA Completed
NCT00892866 2024-05-03
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
GOG Foundation
Phase NA Active not recruiting
NCT03412630 2023-11-24
Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab
Eastern Cooperative Oncology Group
Phase NA Terminated
NCT00499291 2023-05-25
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Eastern Cooperative Oncology Group
Phase NA Withdrawn
NCT00002807 2020-04-06
Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery
Canadian Cancer Trials Group
Phase NA Completed
NCT00958698 2019-03-12
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
GOG Foundation
Phase NA Unknown
NCT01275664 2018-05-22
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
GOG Foundation
Phase NA Terminated
NCT00070317 2017-11-06
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
GOG Foundation
Phase NA Terminated
NCT00551265 2017-07-14
Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy
GOG Foundation
Phase NA Withdrawn
NCT00956670 2017-05-08
LEG
GOG Foundation
Phase NA Unknown
NCT00093678 2015-10-08
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
Eastern Cooperative Oncology Group
Phase NA Withdrawn
NCT00003384 2015-05-29
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer
GOG Foundation
Phase NA Completed
NCT00017134 2013-06-10
Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
GOG Foundation
Phase NA Terminated
NCT00477867 2013-06-10
Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172
GOG Foundation
Phase NA Withdrawn
NCT00040911 2013-05-31
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma
Children's Oncology Group
Phase NA Completed
NCT00004936 2013-01-28
ACRIN 6651
American College of Radiology Imaging Network
Phase NA Completed